Lymphoma Cancer | Tumor

On Demand: Educated Patient® Leukemia and Lymphoma Summit

October 27th 2020, 7:00pm


View the entire CURE® Educated Patient® Leukemia & Lymphoma Summit. A virtual event seeking to educate, inform and challenge the thinking of patients with leukemia and lymphoma.

Friday Frontline: Jeff Bridges Receives a Lymphoma Diagnosis; Controversial Radio Host Rush Limbaugh Announces His Lung Cancer Has Progressed; And More

October 23rd 2020, 3:00pm


From acclaimed actor Jeff Bridges tweeting about a new lymphoma diagnosis to controversial conservative radio host Rush Limbaugh announcing that his stage 4 lung cancer has progressed, here’s what’s happening in the cancer landscape this week.

FDA Approves Keytruda for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma

October 15th 2020, 12:30pm


Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.

What the FDA’s New Breast Implant Recommendations Mean for Patients

September 30th 2020, 6:00pm


In an interview with CURE®, the president of the National Center for Health Research elaborates on the effort to protect patients from potentially serious side effects associated with getting breast implants, including breast implant-associated anaplastic large cell lymphoma.

FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects

September 29th 2020, 5:30pm


New guidance from the Food and Drug Administration recommends that the makers of breast implants include a black-box warning, a patient decision checklist and other information on product labels that will help protect them against a cancer and an autoimmune condition that can arise from use of the devices.

New Therapies for Adults and Children With Blood Cancers Hold Promise

September 25th 2020, 9:00pm


In this special hematology focused issue of CURE® we look at all the promising treatments and research for both adults and children with blood cancers.

The Price of Hope: Weighing the Cost of CAR-T Cell Therapy in Treating Blood Cancers

September 23rd 2020, 3:00pm


Weighing the cost of CAR-T cell therapy in treating blood cancers is a finical burden for many patients with blood cancer.

CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day

September 10th 2020, 9:00pm


Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.

5 Reports on Lymphoma Patients May Have Missed

August 31st 2020, 1:00pm


CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.

FDA Provides Updated Analysis of Breast Implant-Associated Lymphoma, Breast Implant Illness

August 21st 2020, 6:00pm


The FDA also released a video for patients that details seven things they should know about breast implants, including information about breast implant-associated lymphoma and systemic symptoms.